CompletedNot Applicable

AESOPS Trial 2 (AESOPS-2): Availability of Opioid Harm

United States61 participantsStarted 2023-01-23

Plain-language summary

The opioid epidemic is the largest man-made public health crisis the United States has faced. The objective of Trial 2 of the Application of Economics \& Social psychology to improve Opioid Prescribing Safety (AESOPS-2) study, is to discourage unnecessary opioid prescribing by increasing the salience of negative patient outcomes associated with opioid use.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * 1\) The clinician prescribed a qualifying scheduled drug to a patient in the 12 months prior to their non-fatal or fatal overdose 2) the patient is 18 years old or older at the time of the overdose, 3) the provider practices within a health system enrolled in the study, and 4) the overdose occurs during the 12-month observation period. Qualifying prescriptions include those for one of the following scheduled drugs: opioids, benzodiazepines, muscle relaxants or sedative-hypnotics. Exclusion Criteria: * Prescriptions to patients in hospice or with active cancer

What they're measuring

Change in Daily Average Number of 5 MME Pill Counts

Timeframe: 13 months (6 months pre-intervention, 30-day washout period, 6 months post-intervention)

Trial details

NCT IDNCT04758637

SponsorUniversity of Southern California

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-03-18

Results submitted2025-03-18

View on ClinicalTrials.gov More Opioid Abuse trials